Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Allergan plc | d768203d8k.htm |
Exhibit 99.1
Actavis Pharma Segment Revenue
| (Unaudited; $ in millions) | Six Months Ended June 30, 2014 |
Three Months Ended June 30, 2014 |
Three Months Ended March 31, 2014 |
Twelve Months Ended December 31, 2013 |
Three Months Ended December 31, 2013 |
Three Months Ended September 30, 2013 |
Three Months Ended June 30, 2013 |
Three Months Ended March 31, 2013 |
Twelve Months Ended December 31, 2012 |
Twelve Months Ended December 31, 2011 |
||||||||||||||||||||||||||||||
| North American Brands |
||||||||||||||||||||||||||||||||||||||||
| Lo Loestrin® Fe |
$ | 130.4 | $ | 68.0 | $ | 62.4 | $ | 63.3 | $ | 63.3 | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||||||||||
| Minastrin® 24 Fe |
104.4 | 56.5 | 47.9 | 55.7 | 55.7 | — | — | — | — | — | ||||||||||||||||||||||||||||||
| Estrace® Cream |
111.2 | 57.9 | 53.3 | 60.7 | 60.7 | — | — | — | — | — | ||||||||||||||||||||||||||||||
| Other Women’s Health |
97.4 | 48.4 | 49.0 | 113.1 | 44.9 | 26.9 | 21.3 | 20.0 | 61.9 | 32.5 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Women’s Health |
443.4 | 230.8 | 212.6 | 292.8 | 224.6 | 26.9 | 21.3 | 20.0 | 61.9 | 32.5 | ||||||||||||||||||||||||||||||
| Rapaflo® |
56.5 | 25.3 | 31.2 | 96.5 | 25.8 | 26.8 | 21.3 | 22.6 | 71.1 | 55.6 | ||||||||||||||||||||||||||||||
| Delzicol®/Asacol® HD |
277.2 | 136.4 | 140.8 | 150.2 | 150.2 | — | — | — | — | — | ||||||||||||||||||||||||||||||
| Other Urology/Gastroenterology |
106.0 | 52.8 | 53.2 | 162.1 | 60.1 | 33.4 | 34.5 | 34.1 | 146.6 | 153.4 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Urology/Gastroenterology |
439.7 | 214.5 | 225.2 | 408.8 | 236.1 | 60.2 | 55.8 | 56.7 | 217.7 | 209.0 | ||||||||||||||||||||||||||||||
| Doryx® |
29.4 | 17.5 | 11.9 | 31.0 | 31.0 | — | — | — | — | — | ||||||||||||||||||||||||||||||
| Actonel ® |
115.3 | 54.2 | 61.1 | 63.1 | 63.1 | — | — | — | — | — | ||||||||||||||||||||||||||||||
| Other Dermatology/Established Brands |
153.4 | 70.2 | 83.2 | 266.8 | 80.3 | 65.9 | 67.7 | 52.9 | 198.6 | 190.6 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Dermatology/Established Brands |
298.1 | 141.9 | 156.2 | 360.9 | 174.4 | 65.9 | 67.7 | 52.9 | 198.6 | 190.6 | ||||||||||||||||||||||||||||||
| Total North American Brands |
1,181.2 | 587.2 | 594.0 | 1,062.5 | 635.1 | 153.0 | 144.8 | 129.6 | 478.2 | 432.1 | ||||||||||||||||||||||||||||||
| North American Generics |
2,055.6 | 1,031.4 | 1,024.2 | 3,915.7 | 1,033.1 | 976.1 | 949.8 | 956.7 | 3,472.2 | 2,945.6 | ||||||||||||||||||||||||||||||
| International |
1,268.3 | 621.6 | 646.7 | 2,502.5 | 728.1 | 576.8 | 619.4 | 578.2 | 978.1 | 430.5 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
| Net Revenues |
$ | 4,505.1 | $ | 2,240.2 | $ | 2,264.9 | $ | 7,480.7 | $ | 2,396.3 | $ | 1,705.9 | $ | 1,714.0 | $ | 1,664.5 | $ | 4,928.5 | $ | 3,808.2 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Our North American Brands Revenue consists of three categories: Women’s Health, Urology/Gastroenterology, and Dermatology/Established Brands. The products that make up each category are as follows:
| Women’s Health |
Urology/Gastroenterology |
Dermatology/Established Brands | ||||
| Atelvia® | Androderm® | Cordran® Tape | Tri-Norinyl® | |||
| Crinone® | Asacol® | Doryx® | Oxytrol® | |||
| Estrace® Cream | Asacol® HD/Asacol® 800 | Actonel® | Gelnique® | |||
| Generess® Fe | Delzicol® | Actonel DR® | Sodium Ferric Gluconate | |||
| Lo Loestrin® Fe | Enablex® | INFeD® | Actigall® | |||
| Loestrin® 24 Fe | Rapaflo® | Kadian® | Condylox® | |||
| Minastrin® 24 Fe | Trelstar® | Alora® | Fioricet® | |||
| Fibristal™ | AndroGel® Copromotion Revenue |
Brevicon® | Fiorinal® | |||
| ella® | Norco® | |||||
| Estrace® Tablets | Microzide® | |||||
| Femring® | Femcon® Fe | |||||
| Norinyl® | femhrt® | |||||
| Nor-QD® | Sarafem® | |||||
| PapSure® | Estrostep® Fe | |||||
| PreQue 10™ | Ovcon® | |||||
| Royalty, Supply & Other Revenue | ||||||